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Viral encephalomyelitis
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Viral infections have long been implicated as triggers of autoimmune diseases, including 
multiple sclerosis (MS), a central nervous system (CNS) inflammatory demyelinating 
disorder. Epitope spreading, molecular mimicry, cryptic antigen, and bystander acti-
vation have been implicated as mechanisms responsible for activating self-reactive 
(SR) immune cells, ultimately leading to organ-specific autoimmune disease. Taking 
advantage of coronavirus JHM strain of mouse hepatitis virus (JHMV)-induced demye-
lination, this study demonstrates that the host also mounts counteractive measures to 
specifically limit expansion of endogenous SR T cells. In this model, immune-mediated 
demyelination is associated with induction of SR T cells after viral control. However, their 
decline during persisting infection, despite ongoing demyelination, suggests an active 
control mechanism. Antigen-specific IL-10-secreting CD4+ T cells (Tr1) and Foxp3+ 
regulatory T cells (Tregs), both known to control autoimmunity and induced following 
JHMV infection, were assessed for their relative in  vivo suppressive function of SR 
T cells. Ablation of Foxp3+ Tregs in chronically infected DEREG mice significantly increased 
SR CD4+ T cells within cervical lymph nodes (CLN), albeit without affecting their numbers 
or activation within the CNS compared to controls. In contrast, infected IL-27 receptor 
deficient (IL-27R−/−) mice, characterized by a drastic reduction of Tr1 cells, revealed that 
SR CD4+ T cells in CLN remained unchanged but were specifically increased within the 
CNS. These results suggest that distinct Treg subsets limit SR T cells in the draining 
lymph nodes and CNS to maximize suppression of SR T-cell-mediated autoimmune 
pathology. The JHMV model is thus valuable to decipher tissue-specific mechanisms 
preventing autoimmunity.
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Abbreviations: APC, antigen-presenting cell; BBB, blood–brain barrier; CLN, cervical lymph node; CNS, central nervous 
system; DT, diphtheria toxin; DTR, diphtheria toxin receptor; EAE, experimental autoimmune encephalomyelitis; HSV, herpes 
simplex virus; LFB, Luxol fast blue; MHV, mouse hepatitis virus; MBP, myelin basic protein; MOG, myelin oligodendrocyte 
glycoprotein; MS, multiple sclerosis; SR, self-reactive; TMEV, Theiler’s murine encephalomyelitis virus; Tregs, regulatory T 
cells; Tr1, type 1 regulatory cells.
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inTrODUcTiOn
Viruses have long been associated with autoimmune diseases 
of the central nervous system (CNS), such as multiple sclerosis 
(MS), both as potential inducers and as facilitators of a self-
reactive (SR) immune response (1, 2). While the detection of 
viral antigens and antiviral antibodies in MS brains supports a 
role for viral infections in triggering autoimmunity (3–5), the 
“hygiene hypothesis” rather proposes a protective function (6, 7), 
underlining the ambiguous link between viral infections and MS 
(8). This dichotomy between viral infections and autoimmune 
diseases is reflected in two prominent models of viral-induced 
demyelination, i.e., Theiler’s murine encephalomyelitis virus 
(TMEV) and neurotropic mouse hepatitis virus (MHV). During 
persistent TMEV infection, activation of SR T cells by epitope 
spreading triggers an autoimmune disease characterized by 
demyelination and ascending paralysis (9, 10). By contrast, 
despite ongoing demyelination, persistent neurotropic MHV 
infections are defined by clinical recovery with no evidence for 
autoimmune-mediated clinical symptoms (11, 12). Nevertheless, 
our recent study demonstrated that endogenous SR T cells are 
activated specifically during chronic infection, correlating with 
kinetics of JHM strain of mouse hepatitis virus (JHMV)-induced 
demyelination (13). However, the endogenous SR T cell response 
declined despite sustained myelin loss during viral persistence and 
the preserved ability of antigen-presenting cells from both cervi-
cal lymph nodes (CLN) and the CNS to activate myelin-specific 
CD4+ T cells ex vivo. These findings suggested that chronic JHMV 
infection actively induces suppressive mechanisms to limit the 
development of autoimmunity.
Immune regulation associated with viral infections requires 
a delicate balance between promoting effective virus clearance 
while limiting tissue damage. This is especially critical within 
the CNS due to its limited regenerative capacity. Following 
JHMV infection, T cells primarily control infectious virus 
within the brain and spinal cords within 2 weeks. Nevertheless, 
viral persistence is evident by ongoing detection of viral RNA 
predominantly within spinal cords. Demyelination is initiated 
during T cell-mediated control of viral replication, peaks sub-
sequent to virus control, but continues throughout persistence 
(12). Induction of Foxp3+ regulatory T cell (Tregs) and type 
1 regulatory T (Tr1) cells and their migration to the CNS are 
already evident during the acute infection (14, 15). Both regula-
tory populations are known to control autoimmune diseases (16, 
17). Prior studies of their role during JHMV infection demon-
strated that Tr1 cells have a limited effect on tissue damage (15), 
while Foxp3+ Tregs restrict the extent of demyelination without 
affecting viral persistence (18, 19). Indeed, depletion of CD25+ 
regulatory CD4+ T cells prior JHMV infection correlated with 
increased myelin loss during viral persistence (19). Similarly, 
transfer of naive Foxp3+ Tregs into acutely JHMV-infected 
mice improved clinical disease and restricted tissue damage 
without altering control of virus replication (20). The limited 
role of Foxp3+ Tregs in virus clearance was also confirmed by 
unaltered antiviral T cell responses following Foxp3+ Treg deple-
tion during acute infection with the less pathogenic MHV-A59 
strain (21). However, the same study showed that Foxp3+ Tregs 
limited proliferation of transferred SR T cells in the CLN (21). 
Altogether, these data support the notion that Foxp3+ Tregs 
limit tissue damage by specifically counteracting the activation 
of endogenous SR T cells, without apparent affects on antiviral 
T cells. However, in all these studies, transfer or depletion of 
Foxp3+ Tregs were performed during acute MHV infection, 
prior to the induction of endogenous SR T cells (13), limiting 
knowledge of their function during persistence. Regulation of 
in vivo primed SR T cells and immunopathology by endogenous 
Foxp3+ Treg during persistence remains unexplored.
To assess how Foxp3+ Treg depletion affects endogenous SR 
T cells during JHMV persistence, we chose DEREG mice, which 
express the human diphtheria toxin (DT) receptor under the con-
trol of the Foxp3 promoter (22). Incomplete DT-mediated Foxp3+ 
Treg depletion in naive adult DEREG mice is advantageous to 
our studies as it enables a window to study effects of Foxp3+ Treg 
ablation on myelin reactive CD4+ T cells without confounding 
complications of lymphoproliferative disease and systemic 
lethal autoimmunity (23, 24). DT treatment of JHMV-infected 
DEREG mice at the peak of SR T cell CNS infiltration (between 
days 21 and 28 post infection), resulted in increased lymphocyte 
expansion and T cell activation in CLN, coincident with elevated 
pro-inflammatory cytokine expression compared to DT-treated 
controls. More importantly, Foxp3+ Treg ablation specifically 
increased frequencies of myelin-specific but not virus-specific 
CD4+ T cells, indicating preferential regulation of peripheral SR 
T cells by Foxp3+ Tregs. Surprisingly however, CNS inflammation, 
viral persistence, and demyelination remained similar consistent 
with no changes in virus and myelin-specific CD4+ T cells within 
the CNS. The apparent redundant role of Foxp3+ Tregs in regulat-
ing CNS inflammation implied a potential protective function of 
Tr1 cells. Analysis of SR T cells during chronic JHMV infection 
of IL-27R−/− mice, which lack Tr1 cells, revealed no effects within 
the CLN. By contrast, both virus-specific and SR CD4+ T cells 
were increased within the CNS of IL-27R−/− relative to wild-type 
(WT) mice. Altogether, these data indicate differential regulation 
of SR CD4+ T cells within the CLN versus CNS during chronic 
JHMV infection. While Foxp3+ Tregs specifically control myelin-
specific CD4+ T cells within CLN, Tr1 cells limit SR T cells within 
the CNS.
MaTerials anD MeThODs
Mice, infection, and Foxp3+ Treg Depletion
C57BL/6 WT mice were purchased from the National Cancer 
Institute (Frederick, MD, USA). C57BL/6 DEREG mice, which 
express the enhanced green fluorescent protein (eGFP) and 
diphtheria toxin receptor (DTR) under the control of the Foxp3 
promoter, were kindly provided by Dr. T. Sparwasser (Twincore, 
Hannover, Germany) (22). C57BL/6 homozygous IL-27Rα 
(WSX-1) deficient (IL-27R−/−) mice were provided by Dr. C. 
Saris (Amgen, Thousand Oaks, CA, USA). Mice were bred and 
maintained at the Biological Resources Unit of the Cleveland 
Clinic Lerner Research Institute under sterile conditions. All pro-
cedures were performed in compliance with protocols approved 
by the Cleveland Clinic Institutional Animal Care and Use 
Committee. Mice of both sexes at 6–7 weeks of age were infected 
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in the left hemisphere with 1,000 plaque forming unit (PFU) 
of the sublethal gliatropic JHMV monoclonal antibody (mAb) 
derived variant designated 2.2v-1 (25) in 30-μl endotoxin-free 
Dulbecco’s phosphate-buffered saline (PBS). Mice were assessed 
daily for clinical disease severity according to the following scale: 
0, healthy; 1, hunched back and ruffled fur; 2, partial hind limb 
paralysis or inability to maintain the upright position; 3, complete 
hind limb paralysis; 4, moribund or dead. For Foxp3+ Treg deple-
tion, DEREG mice and control littermates (Foxp3eGFPDTR− mice) 
received daily intraperitoneal (i.p.) injections of 1-μg DT (EMD 
Biosciences, San Diego, CA, USA) between days 21 and 28 post 
infection (p.i.).
Tissue Processing for cell isolation
Mice were perfused with ice cold PBS before harvesting CLN, 
spleen (SPL), brain, and spinal cord. CLN were dissociated 
through a cell strainer and single cell suspensions washed and 
resuspended in RPMI 1640 medium. For splenocyte isolation, 
tissues were dissociated, treated with Gey’s solution to lyse red 
blood cells, and washed twice in RPMI 1640 medium. To isolate 
CNS infiltrating cells, brains and spinal cords were homogenized 
in 4-ml Dulbecco’s PBS using TenBroeck tissue grinders as 
described (26). Tissue homogenates were adjusted to 30% Percoll 
(Pharmacia, Uppsala, Sweden) and underlayed with 1-ml 70% 
Percoll. Following centrifugation at 850  g for 30  min at 4°C, 
mononuclear cells were recovered from the 30–70% interface and 
washed with RPMI 1640 medium.
Flow cytometry
Cells were resuspended in FACS buffer (Dulbecco’s PBS +  1% 
bovine serum albumin). Non-specific staining was blocked with 
mouse serum and anti-mouse CD16/CD32 (clone 2.4G2, BD 
Biosciences, San Jose, CA, USA) for 15 min on ice. Cells were 
stained for 30 min on ice with fluorescein isothiocyanate (FITC), 
phycoerythrin (PE), peridin chlorophyll protein (PerCP), or 
allophycocyamin (APC) conjugated mAb (all for BD Biosciences 
expect when indicated) specific for CD45 (clone Ly-5), CD4 
(clone GK1.5), CD8 (clone 53-6.7), CD11b (M1/70), CD25 
(clone PC61), MHC class II (clone 2G9), CD44 (clone IM7), 
CD62L (clone MEL-14), CD69 (clone H1-2F3), and CXCR3 
(R&D Systems, Minneapolis, MN, USA). Virus-specific CD8 
T  cells were characterized using H-2Db/S510 MHC class I 
tetramers (27). Intracellular staining for Foxp3 (eBioscience, San 
Diego, CA, USA) was performed according to the manufacturer’s 
instructions. Cells were washed twice with FACS buffer and ana-
lyzed using a FACSCalibur flow cytometer (BD Biosciences) and 
FlowJo software (Tree Star Inc., Ashland, OR, USA).
rna extraction, reverse Transcription, 
and gene expression analysis
Snap-frozen tissues were homogenized in TRIzol (Invitrogen, 
Carlsbad, CA, USA) using a TissueLyser and stainless steel beads 
(Qiagen, Valencia, CA, USA). RNA was extracted according 
to manufacturer’s instructions. Briefly, RNA was extracted by 
adding chloroform prior to centrifugation at 12,000 g for 15 min 
at 4°C. RNA was then precipitated with isopropyl alcohol, 
washed with 75% ethanol, and resuspended in RNase-free water. 
DNA contamination was eliminated by DNase I treatment for 
30  min at 37°C (DNA-free kit, Ambion, Austin, TX, USA). 
cDNA was synthesized by reverse transcription using Moloney 
murine leukemia virus reverse transcriptase (Invitrogen) and a 
mixture of oligo(dT) (10  mM) (Promega, Madison, WI, USA) 
and 250  ng random primers (Promega). Gene expression 
analysis was performed by quantitative real-time PCR (qPCR) 
using SYBR Green or Taqman master mixes on a 7500 Fast 
real-time PCR system (Applied Biosystems, Foster City, CA, 
USA). SYBR Green primers used for transcripts were as fol-
lows: GADPH, 5′-TGCACCACCAACTGCTTAG-3′ (sense) 
and 5′-GGATGCAGGGATGATGTTC-3′ (antisense); JHMV 
nucleocapsid, 5′-CGCAGAGTATGGCGACGAT-3′ (sense) 
and 5′-GAGGTCCTAGTCTCGGCCTGTT-3′ (antisense); IL-2, 
5′-CAGGATGGAGAATTACAGGAACCT-3′ (sense) and 5′-TTT 
CAATTCTGTGGCCTGCTT-3′ (antisense); CCL5, 5′-GCAA 
GTGCTCCAATCTTGCA-3′ (sense) and 5′-CTTCTCTGGGTT 
GGCACACA-3′ (antisense); CXCL9, 5′-TGCACGATGCTCCT 
GCA-3′ (sense) and 5′-AGGTCTTTGAGGGATTTGTAGTGG-3′ 
(antisense); and CXCL10, 5′-GACGGTCCGCTGCAACTG-3′ 
(sense) and 5′-GCTTCCCTATGGCCCTCATT-3′ (antisense). 
GAPDH, interferon gamma (IFN-γ), and CCL2 mRNA levels 
were determined using TaqMan primers. Transcript levels were 
normalized to the levels of the housekeeping gene GAPDH by 
using the formula 2[Ct(GAPDH) − Ct(gene)] × 1,000, where Ct repre-
sents the threshold cycle value.
Peptides and enzyme-linked 
immunosPOT assay
Virus (M133)-, myelin oligodendrocyte glycoprotein (MOG)- 
and myelin basic protein (MBP)-specific CD4 T cells were 
detected by Enzyme-Linked ImmunoSPOT (ELISPOT) assay 
as described (13). Briefly, 96-well plates were coated with 
IFN-γ capture Ab (BD Biosciences). Serial dilutions of cells 
were cultured for 36 h at 37°C in RPMI complete (RPMI 1640 
medium containing 2-mM l-glutamine, non-essential amino 
acid, 1-mM sodium pyruvate, 25-μg/ml gentamycine, and 
5 × 10−5M 2-mercaptoethanol) supplemented with 10% fetal calf 
serum in the presence of stimulator splenocytes preincubated 
with or without 1-μM peptide (M133−147, GTVYVRPIIEDYHT; 
MOG35−55, MEVGWYRSPFSRVVHLYRNGK; MBP60−80, 
SHHAARTTHYGSLPQKSQR; Bio-Synthesis, Lewisville, TX, 
USA). Spots were detected by sequential incubation with bioti-
nylated anti-IFN-γ mAb (BD Biosciences) overnight at 4°C, 
horseradish peroxidase conjugated streptavidin (BD Biosciences) 
for 1  h at room temperature and 3,3′-diaminobenzidine sub-
strate (Sigma–Aldrich, St. Louis, MO, USA). Numbers of spots 
were determined using a CTL ImmunoSpot analyzer (Cellular 
Technology Ltd., Shaker Heights, OH, USA). Spots detected in 
wells with no peptide (negative control) were subtracted from 
spots formed in the presence of peptide and results presented as 
the number of IFN-γ secreting cells normalized to 106 input cells.
histopathological analysis
After PBS perfusion, spinal cords were fixed in 10% zinc formalin, 
divided into six sections (two per cervical, thoracic, and lumbar 
regions) prior embedding in paraffin. Then, 6 μm cross sections 
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were stained with Luxol fast blue (LFB) to visualize demyeli-
nated lesions. To determine the percentage of demyelination, 
LFB-stained sections of all six levels per individual mouse were 
scanned with an Aperio ScanScope (Vista, CA, USA) at 40× 
and areas of demyelination within the white matter tracks were 
quantify using Aperio software.
statistical analysis
Data represent the mean  ±  SEM and were plotted using 
Graphpad prism 5.0 software (Graphpad Software Inc., La Jolla, 
CA, USA). Statistical analysis was performed using a Mann–
Whitney test, Dunn’s multiple comparison test, and ANOVA 
with Bonferroni post-test. p-Values <0.05 were considered 
statistically significant.
resUlTs
Dynamics of Foxp3+ Tregs and Depletion 
in Dereg Mice during chronic JhMV 
infection
Foxp3+ Tregs infiltrate the CNS during acute JHMV infection 
and are retained together with both virus-specific and SR T cells 
during persistence (13, 19). However, their role in regulating 
endogenously primed T cell populations of viral, and more 
importantly, SR specificity has not been addressed. To specifically 
investigate a function of Foxp3+ Tregs during JHMV persistence, 
we infected DEREG mice, in which DT treatment abrogated the 
vast majority of Foxp3+ Tregs under homeostatic conditions but 
retained a minor fraction thereby circumventing lymphoprolif-
erative disease (22). We first confirmed that transgene expression 
in DEREG mice does not alter JHMV pathogenesis compared 
to syngeneic WT mice. Clinical disease onset and progression, 
viral clearance, and CNS inflammatory responses were similar 
between the two groups (data not shown). The extent and sever-
ity of demyelination within spinal cords was also not altered 
(data not shown). Moreover, high fluorescent intensity of eGFP 
expressed under control of the Foxp3 promoter in DEREG mice 
enabled a distinct separation of the Foxp3+ population among 
CD4+ T cells compared to direct intracellular Foxp3-staining in 
WT mice (Figure 1A). Most importantly, no significant differ-
ences in the frequency of Foxp3+ cells within CD4+ T cells during 
JHMV infection were found comparing the two groups (data not 
shown). Validation of Foxp3 expression in DEREG mice thus 
facilitated characterization of Foxp3+ Treg kinetics during the 
course of infection. The frequency of Foxp3+ cells within CD4+ 
cells remained stable at ~15% within CLN at all time points 
(data not shown). By contrast, within both brain and spinal cord, 
Foxp3+ cells within CD4+ T cells peaked at day 7 p.i. and then 
rapidly decreased at day 10 p.i. (Figure  1B). However, while 
the frequency of Foxp3+ Tregs was maintained at ~10% within 
the brain after day 10 p.i. (Figure 1B), a sustained rebound was 
observed in spinal cords after day 14 p.i. during chronic infection 
(Figure  1B). The sustained increase in the fraction of Foxp3+ 
Tregs at later time points, specifically within the spinal cord, was 
not attributed to viral replication, as infectious virus is cleared 
by day 14 p.i., and viral RNA levels continuously decline after 
day 10 p.i. (15). Onset of robust demyelination in spinal cords at 
day 14 p.i. (12) rather implicates that the second wave of Tregs 
is pathology-driven and functions to limit emerging SR CD4+  
T cell responses.
Based on the delayed expansion of endogenous SR CD4+ 
T cells coincident with onset of demyelination and rebound of 
Tregs in spinal cords during chronic infection (13), we assessed the 
effect of Treg depletion during viral persistence. JHMV-infected 
DEREG mice (DTR+) and their control littermates (DTR−) were 
treated daily with DT at the peak of SR CD4+ T cell response 
between days 21 and 28 p.i. (13). Foxp3+ Treg frequencies were 
70% reduced at day 28 p.i. in both CLN and CNS of DTR+ mice 
(Figures 1C,D). By contrast, control DTR− treated mice revealed 
no alteration of Foxp3+ T cell frequencies in CLN and CNS 
after DT treatment (Figures 1C,D). These results confirmed the 
specificity of DT-mediated Foxp3+ Treg depletion as well as their 
residual presence due to incomplete abrogation and rebound after 
ongoing DT treatment (23, 28).
Foxp3+ Tregs regulate cln inflammation
Initial T cell activation of both virus- and myelin-specific CD4+ 
T cells occurs within CLN (13, 29), consistent with anatomical 
linkage between deep CLN and CNS by the meningeal lymphatic 
system (30). Transfer of Foxp3+ Tregs during acute JHMV infec-
tion limited CNS tissue damage by inhibiting T cell proliferation 
within CLN and reducing overall T cell numbers within the 
CNS, yet without affecting frequencies of virus-specific T cells 
(20). These studies predicted that Foxp3+ Treg depletion during 
chronic JHMV infection would increase T cell numbers in CLN 
and CNS. DT-treated DTR+ mice indeed exhibited a threefold 
increase in CLN cellularity compared to DTR− controls between 
days 21 and 28 p.i. (Figure  2A). However, overall CD4+ and 
CD8+ T cell proportions were not altered suggesting the cellular 
increase was not lymphocyte specific (Figure  2B). Analysis of 
T cell activation following Treg depletion revealed a significant 
increase in CD62LlowCD44hi populations in both the CD4+ and 
CD8+ T cell subset (Figure 2C). Contrasting increased activation 
in CLN, DTR− and DTR+ mice showed no difference in total 
numbers of splenocytes 1  week after DT treatment (data not 
shown), suggesting specific regulation in CLN.
Enhanced activation specifically in CLN of DT-treated DEREG 
mice during persistence may be polyclonal and/or driven by low 
levels of residual viral or auto-antigen presentation in CLN (12, 
13). The increased T cell effector cell phenotype indeed correlated 
with elevated levels of mRNA for T cell derived pro-inflammatory 
cytokines IFN-γ and IL-2 (Figure 2D). Although there is no evi-
dence suggesting peripheral virus replication during persistent 
infection, the presence of JHMV within CNS-draining lymph 
nodes was indeed supported by detection of low levels of mRNA 
encoding the viral nucleocapsid (N) protein in control DTR− mice 
(Figure 2D). In contrast, increased T cell activation correlated 
with a reduction of viral N mRNA to below detection within CLN 
of DTR+ mice at day 28 p.i. (Figure 2D). Since IFN-γ has antiviral 
activity (31, 32), elevated IFN-γ as a result of increased antiviral 
T cell activity in the absence of Treg is consistent with a decline 
in viral RNA.
To directly assess whether elevated T cell activation is antigen 
driven or more polyclonal in nature, we measured the frequencies 
FigUre 1 | Kinetics of cns localized Foxp3+ Tregs and depletion in infected DT-treated Dereg mice. (a) Representative flow cytometry density plots 
depicting intracellular Foxp3 and eGFP staining in brain-derived CD4+ T cells from WT and DEREG mice, respectively, at day 7 p.i. (B) Frequencies of Foxp3+ cells in 
CD4+ T cells derived from brain and spinal cord of infected DEREG mice between days 7 and 30 p.i. Data represent the mean ± SEM of three separate experiments 
with n = 3 per time point per experiment. *p < 0.05, **p < 0.01, ***p < 0.001, Dunn’s multiple comparison test (c) Representative flow cytometry plots depicting 
Foxp3+CD25+ cells gated on CD4+ T cells from CLN and CNS before (d21 p.i.) and after (d28 p.i.) DT treatment of DTR− and DTR+ mice. (D) Percentage of Foxp3+ 
cells in CD4+ T cells from CLN (top) and CNS (bottom) before (d21) and after (d28) DT treatment in DTR− and DTR+ mice. Data represent the average ± SEM of four 
individual experiments. *p < 0.05, Mann–Whitney test.
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of both virus-specific as well as SR CD4+ T cells in CLN following 
Foxp3+ Treg depletion. Frequencies of virus-specific CD4+ T cells, 
as analyzed by IFN-γ secreting cells following viral peptide M133 
stimulation, were not altered in DTR+ compared to DTR− mice 
(Figure 3). However, reflecting overall increased cellularity, their 
absolute numbers increased more than threefold (Figure 3). We 
next assessed how Foxp3+ Tregs regulate SR-specific CD4+ T cells 
in CLN. Similar to virus-specific CD4+ T cells, myelin-specific 
endogenous CD4+ T cells are activated in CLN, albeit at later 
times correlating with demyelination (13). More importantly, 
APC presenting myelin Ag are present in CLN of chronically 
infected mice (13). Analysis of SR IFN-γ-secreting MOG35−55 and 
MBP60−80 specific CD4+ T cell frequencies revealed a threefold 
increase following Foxp3+ Treg depletion compared to the very 
low frequencies in DT-treated DTR− mice (~30 cells per 106 CLN 
cells; Figure 3). Higher frequencies of SR T cells thus correlated 
with an overall ninefold increase of MOG35−55 and MBP60−80 
specific CD4+ T cell numbers within the CLN of DTR+ mice com-
pared to controls (Figure 3). These data indicated that Foxp3+ 
Tregs unspecifically regulate overall CLN cellularity and T cell 
activation during JHMV persistence but specifically limit expan-
sion of SR CD4 T cells emerging after onset of demyelination.
FigUre 2 | increased cln inflammatory response in absence of Foxp3+ Tregs. (a) Total number of cells within CLN of DT-treated DTR− and DTR+ mice at 
d28 p.i. Data represent the mean ± SEM of five to eight individual experiments. **p < 0.01, Mann–Whitney test. (B) Frequency of CD4 (n = 13) and CD8 (n = 4) T 
cells within CLN of DTR− and DTR+ mice treated with DT between days 21 and 28 p.i. Data represent the mean ± SEM (c) Flow cytometry dot plots of CD62L and 
CD44 expression on CD4+Foxp3− cells and CD8+ T cells derived from CLN of DT-treated DTR− and DTR+ mice at d28 p.i., representative of two separate 
experiments with n = 4 per group per experiment. (D) IFN-γ, IL-2, and JHMV N mRNA expression relative to GAPDH mRNA within CLN of DT-treated DTR− and 
DTR+ mice at d28 p.i. Dots represent individual mice with n = 5–6 per group, and horizontal bars indicate mean number. **p < 0.01, Mann–Whitney test.
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Foxp3+ Tregs Do not regulate cns 
inflammation or Virus control during 
Persistence
Increased CLN activation in absence of Foxp3+ Tregs suggested 
CNS inflammatory responses are also increased in analogy to 
Treg supplementation results by Trandem et al. (20). Surprisingly 
however, Foxp3+ Treg depletion altered neither total CNS cel-
lular infiltration (Figure  4A) nor frequencies of inflammatory 
leukocytes (Figure 4B) at d28 p.i. Percentages of CD11b+, CD4+, 
and CD8+ T cells, including virus-specific CD8+, all remained 
similar irrespective of Foxp3+ Treg depletion (Figures  4C,D). 
T cell activation in the CNS cannot readily be deduced by their 
phenotype as the majority of CD4+ and CD8+ T cells express a 
CD44+CD62LlowCD69+ effector phenotype throughout infection 
(27). Nevertheless, as anticipated, we found no phenotypic T cell 
differences in DT-treated DTR− compared to DTR+ mice (data not 
shown). Similar overall T cell effector function was supported by 
identical levels of mRNA encoding pro-inflammatory cytokines 
IFN-γ and IL-2 in both brain and spinal cord (Figure 4E). No 
apparent differences in T cell numbers or function were also 
reflected in identical levels of persisting viral mRNA in both 
brains and spinal cords (Figure  4F). These data indicated that 
viral persistence was not regulated by Foxp3+ Tregs, distinct from 
CLN. Finally, no overt differences in demyelination in Foxp3+ 
Treg ablated mice indicated a minor, if any, role of this Treg subset 
FigUre 3 | Foxp3+ Tregs control peripheral sr cD4+ T cell response during chronic JhMV infection. Frequencies and absolute numbers of virus-specific 
M133, myelin-specific MOG35−55, and MBP60−80 CD4+ T cells in CLN of JHMV-infected DTR− and DTR+ mice treated with DT between d21 and d28 p.i. determined by 
ELISPOT. The Number of spots detected in wells without stimulation was subtracted to exclude non-specific CD4+ T cells. Data represent the mean of two separate 
experiments with seven to eight pooled mice per group per experiment. *p < 0.05, *p < 0.01, Mann–Whitney test.
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in CNS tissue damage (Figure  4G). These data demonstrated 
that Foxp3+ Tregs control T cell activation and inflammatory 
responses within CLN but have no effect on CNS inflammation 
and pathology during chronic JHMV infection.
Foxp3+ Tregs Do not regulate Virus-
specific or sr cD4+ T cells in the cns
While neither CNS antiviral function nor demyelination were 
affected by Foxp3+ Treg depletion, a potential increase in 
virus-specific and SR CD4+ T cells may be unapparent due to 
their low frequencies in the CNS. Specifically, SR CD4+ T cell 
frequencies are low within the CNS, although higher than in CLN 
(13). To verify that their increased numbers in CLN do not lead 
to enhanced circulation and recruitment to the CNS, we used 
ELISPOT to determine frequencies of both virus-specific and 
SR T cells in the CNS. Frequencies as well as total numbers of 
IFN-γ secreting M133-specific CD4+ T cells were indeed similar in 
the CNS of both groups (Figure 5). Contrasting the CLN, both 
frequencies and total numbers of IFN-γ secreting MOG35−55- and 
MBP60−80-specific CD4+ T cells were also identical within the CNS 
of DT-treated DTR− and DTR+ mice (Figure 5). These data were 
consistent with similar demyelination and supported a limited 
role for Foxp3+ Tregs in controlling the CNS SR CD4+ T cell 
response during chronic JHMV infection.
Increased T cell numbers and activation within CLN after 
Foxp3+ Treg depletion, but no differences in the CNS, implicated 
impaired T cell trafficking. Following JHMV infection, T cell 
migration to the CNS is regulated by CXCR3, as well as CCR2 
and CCR5 (33–35). However, expression of their respective 
ligands, CXCL9, CXCL10, CCL2, and CCL5 was not affected by 
Foxp3+ Treg ablation within brain or spinal cord (Figure  6A). 
However, Foxp3+ Tregs have been reported to limit inflamma-
tory chemokine expression within draining lymph nodes, thereby 
promoting T cell egress (36). Elevated T cell activation and IFN-γ 
mRNA in CLN were indeed associated with significantly increased 
levels of IFN-γ inducible CXCL9 and CXCL10 mRNA levels in 
CLN of Foxp3+ Treg depleted DTR+ mice (Figure 6B). Similarly, 
CXCR3 expression on CD4+ T cells was upregulated in CLN 
(Figure 6C). By contrast, there were no differences in CCL2 and 
CCL5 mRNA expression (Figure  6B), indicating a preferential 
increase of IFN-γ regulated chemokines (37, 38). These results 
supported the notion that enhanced and/or prolonged interac-
tion of CXCR3 ligand expressing APC with CXCR3+ T cells may 
promote retention, thereby limiting T cell egress into circulation 
(39). Overall, these results indicate that Foxp3+ Tregs mediate 
suppressive function primarily within CLN and are more potent 
at controlling peripheral SR T cell activation than virus-specific 
T cells during chronic JHMV infection.
FigUre 4 | Foxp3+ Tregs do not affect cns inflammatory response during chronic JhMV infection. (a) Total cell number and (B) frequency of CNS 
infiltrated leukocytes (CD45hi) from DT-treated DTR− and DTR+ mice at d28 p.i. (c) Percentages of CD11b+, CD4+, and CD8+ T cells within CD45hi cells and 
(D) frequencies of virus-specific CD8+ T cells analyzed at day 28 p.i. by flow cytometry using H-2Db/S510 MHC class I tetramers in DT-treated DTR− and 
DTR+ mice. Data represent the mean ± SEM of at least three individual experiments with n = 4 per group per experiment. Levels of mRNA encoding IFN-γ, 
IL-2 (e), as well as JHMV N (F) in brain and spinal cord of DT-treated DTR− and DTR+ mice at d28 p.i. analyzed by real-time PCR and relative to GAPDH 
mRNA expression. Dots represent individual mice with n = 5–14, and horizontal bars indicate mean number. (g) Percentage of demyelination within white 
matter area analyzed in the spinal cord of DT-treated DTR− and DTR+ mice at d28 p.i. Dots represent individual mouse with n = 7–8 mice per group, and 
horizontal bar indicates mean number.
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FigUre 5 | Foxp3+ Tregs do not affect cns sr T cells during chronic JhMV infection. Frequencies and absolute numbers of virus-specific M133, myelin-
specific MOG35−55, and MBP60−80 CD4+ T cells in CNS of JHMV-infected DTR− and DTR+ mice treated with DT between d21 and d28 p.i. determined by ELISPOT. A 
number of spots detected in wells without stimulation were subtracted to exclude non-specific CD4+ T cells. Data represent the mean of two separate experiments 
with seven to eight pooled mice per group per experiment.
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reduced Tr1 cell response correlates 
with increased cns sr T cells
Unaltered SR T cell responses within the CNS of DT-treated 
DTR+ mice indicated a Foxp3-independent component regulat-
ing the CNS autoimmune response during chronic JHMV infec-
tion. In addition to Foxp3+ Tregs, IL-10-producing Tr1 cells also 
regulate autoimmune responses, including during MS (40, 41). 
Tr1 cells are drastically reduced in JHMV-infected mice deficient 
in IL-27 signaling, a cytokine promoting Tr1 cell response (15). 
Analysis of IL-27R−/− mice further demonstrated that IL-27 does 
not play a pro-inflammatory role or significantly alter CD8 T cell 
function during JHMV infection but is rather a major regulator 
of the Tr1 response (15). Myelin-specific CD4+ T cell responses 
were therefore compared in infected WT and IL-27R−/− mice at 
d30 p.i., the peak of the SR T cell response (13). Opposing the 
results in Foxp3+ Treg depleted mice, frequencies and numbers 
of both virus- and myelin-specific CD4+ T cells were similar 
within CLN of IL-27R−/− mice compared to controls (Figure 7A). 
Furthermore, frequencies of both virus-specific and SR CD4+ 
T cells were significantly increased within the CNS of IL-27R−/− 
mice compared to WT mice (Figure 7B). Interestingly, alteration 
of CD4+ T cell frequencies in the absence of Tr1 cells was more 
prominent for myelin-specific compared to virus-specific T cells 
(fivefold versus twofold, respectively), indicating preferential 
action on SR T cells. Moreover, despite similar overall inflamma-
tory cell numbers, numbers of virus and SR CD4+ T cells were 
increased in the absence of Tr1 cells (Figure 7B). Tr1 cells thus 
do not appear to regulate peripheral SR CD4+ T cell responses 
but act preferentially within the CNS during chronic JHMV 
infection. These data indicate that regulation of SR CD4+ T cell 
response during chronic JHMV infection is dependent upon Tr1 
cells within the CNS, contrasting the specific role of Foxp3+ Tregs 
within CLN.
DiscUssiOn
Viral infections have long been associated with the induction 
and reoccurrence of autoimmune attacks, including MS (1). 
Nevertheless, a firm association between virus and MS remains 
elusive, as active viral replication has thus far never been detected 
within CNS tissue of MS patients. On the other side, a protective 
role of viral infections against autoimmune diseases has also been 
proposed (8), but the mechanisms preventing autoimmunity after 
viral infections remain largely unknown. Among MS murine 
models, JHMV infection reproduces several aspects of MS 
pathogenesis (12). Importantly, tissue damage occurs temporally 
remote from viral infection as indicated by peak demyelination 
after elimination of infectious virus (12). Moreover, lesion size 
FigUre 6 | increased chemokine expression within cln of Foxp3+ 
Treg depleted mice. mRNA expression of CXCL9, CXCL10, CCL2, and 
CCL5 relative to GAPDH at d28 p.i., 1 week after DT treatment, in brain, and 
spinal cord (a), and CLN (B) of DTR− and DTR+ mice with n = 5–6 individual 
mice per group. *p < 0.05, **p < 0.01, Mann–Whitney test. (c) 
Representative flow cytometry density plots depicting CXCR3 surface 
expression within CLN-derived CD4+ T cells in DT-treated DTR− and DTR+ 
mice at d28 p.i. Data are representative of two separate experiments.
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is constrained by IL-10 during persistence independent of viral 
load (42). Lastly, myelin loss correlates with the peripheral 
activation of myelin-specific CD4+ T cells, which access the 
CNS but decline with time despite ongoing demyelination (13). 
The apparent control of the endogenous SR T cells suggested 
suppressive mechanisms prevent ascending clinical autoim-
mune disease during persistent infection. JHMV infection thus 
represents a unique model to assess how viral infection may 
prevent autoimmunity.
As Foxp3+ Tregs are among the regulatory mechanisms damp-
ening JHMV pathogenesis, their implication in controlling SR 
CD4+ T cells was of particular interest. The data herein are novel 
in demonstrating that Foxp3+ Treg abrogation during persistence 
preferentially enhanced endogenously primed, peripheral SR 
CD4+ T cells but had no effect on CNS localized SR T cells or 
tissue damage during chronic JHMV infection. These observa-
tions are consistent with a previous report by Trandem et  al. 
(20) showing that naive Foxp3+ Tregs adoptively transferred into 
acutely JHMV-infected mice were not detected within the CNS 
but rather exerted prominent function within CLN by dampening 
dendritic cell activation, T cell proliferation, and pro-inflamma-
tory cytokine expression. Foxp3+ Treg dependent downregula-
tion of CLN inflammatory response thus correlated with limited 
CNS inflammation and demyelination without affecting viral 
persistence (20). Our results on regulation of SR T cells during 
persistence also corroborated control of transferred SR CD4+ 
T cell proliferation by Foxp3+ Tregs during a heterologous MHV 
infection (21). A primary role of Foxp3+ Tregs within draining 
lymph nodes was also observed in other infectious models, as well 
as during cancer and autoimmunity (36, 43–45). Nevertheless, 
our data differ from results by Trandem et al. with respect to the 
direct correlation between decreased peripheral inflammation 
by Foxp3+ Tregs with decreased CNS cellular infiltration and 
demyelination. Despite extensive expansion of the inflammatory 
response within the CLN of mice depleted of Foxp3+ Tregs during 
persistence, no alteration of CNS inflammation or tissue dam-
age was evident. These differences may reside in the differential 
properties of the blood–brain barrier (BBB) between acute and 
chronic JHMV infection, as BBB permeability is restored to 
naive levels after day 14 p.i. (46), thus potentially limiting effector 
T cell access into the CNS after Foxp3+ Treg depletion. Further, 
enlarged CLN associated with increased chemokine expression 
indicated restricted T cell egress is responsible for the lack of 
altered CNS inflammation. Retention of effector T cells within the 
draining lymph nodes following Foxp3+ Treg depletion was also 
observed during herpes simplex viral (HSV) infection. In  this 
model, Treg-mediated suppression of chemokine production 
within lymph nodes facilitated effector T cell egress and traf-
ficking to the infection site (36). While a similar mode of Treg 
action is supported by our studies, Treg supplementation, rather 
than depletion, enhanced chemokine production and T effector 
cell retention in lymph nodes during experimental autoimmune 
encephalomyelitis (EAE), thereby diminishing CNS T cell migra-
tion (47). All together, these diverse CNS inflammation models 
suggest that Foxp3+ Treg can modulate effector T cells in draining 
lymph nodes both at the expansion phase as well as egress phase. 
The relative balance between expansion and local cytokine/
chemokine expression then ultimately determines egress into 
circulation and access to the CNS.
Irrespective of the overall common suppressive action in 
draining LN during viral infection, the function of endogenous 
Foxp3+ Treg migrating to and residing in the CNS throughout 
persistence remains obscure. Despite the prolonged reduction of 
Tregs by DT-mediated depletion, we found no evidence of altered 
pathogenesis. Regulation of the CNS autoimmune responses by 
Foxp3+ Tregs is also ineffective during EAE (48). Despite Foxp3+ 
Treg accumulation within the inflamed CNS, their functions 
were abrogated by pro-inflammatory cytokines IL-6 and TNF. 
Expression of both cytokines during JHMV infection (49) sug-
gests they may have similar suppressive activity on local Foxp3+ 
Treg. Alternatively, a potential deficit of Foxp3+ Treg access to CNS 
demyelinating lesions, with perivascular retention, may explain 
FigUre 7 | increased cns sr T cell response in absence of Tr1 cells. Frequencies and absolute numbers of virus-specific M133, MOG35−55, and MBP60−80 
specific CD4+ T cells in CLN (a) and CNS (B) derived cells from JHMV-infected WT and IL-27R−/− mice at d30 p.i. determined by ELISPOT. A number of spots 
detected in wells without stimulation were subtracted to exclude non-specific CD4+ T cells. Data represent the mean of two separate experiments with seven to 
eight pooled mice per group per experiment. *p < 0.05, Mann–Whitney test.
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their inability to regulate CNS inflammation and will require 
further investigation. It is also possible that residual Foxp3+ Tregs 
detected 1 week after DT treatment may be sufficient to control 
CNS inflammation. The minor Foxp3+ Treg population detected 
at day 28 p.i. presumably comprises rebound Tregs, as well as a 
small proportion of DT insensitive Foxp3+ cells detected in adult 
DEREG mice (23). While rebound Tregs are dysfunctional (28), 
DT-resistant Foxp3+ Tregs have been shown to protect against 
lethal autoimmunity and may thus suffice to control the SR CD4+ 
T cells during chronic JHMV infection (23). It nevertheless 
remains intriguing that residual Foxp3+ Tregs in CLN appear to 
exert more potent suppressive capacities than in the CNS.
In contrast to the lack of Foxp3+ Treg suppressive function 
within the CNS, IL-27R−/− mice displayed increased virus and 
SR CD4+ T cell responses, implicating Tr1 cells as a major 
regulator of CNS inflammation during chronic JHMV infection. 
Impaired IL-27 signaling was associated with decreased IL-10+ 
virus-specific CD4+ T cells and delayed viral control (15). The 
present results indeed confirmed that Tr1 cells dampened the 
virus-specific Th1 cell response within the CNS. However, a 
greater increase of SR CD4+ T cells was observed in the CNS of 
IL-27R−/− mice, indicating that Tr1 cells are also critical in limit-
ing autoimmunity during chronic JHMV infection. It remains 
to be determined whether Tr1 cells restricting SR CD4+ T cell 
response during chronic JHMV infection are myelin-specific, 
as Tr1 regulatory function efficacy was shown to be dependent 
upon antigen specificity (50, 51). The mechanisms associated 
with Tr1-dependent suppression of CNS SR T cells may involve 
IL-10 secretion, granzyme B, and perforin production, inhibitory 
molecule expression, or metabolic regulation (52). Finally, the 
implication of SR CD4+ T cells in promoting tissue damage and 
clinical autoimmunity during JHMV infection remain unclear, 
as increased myelin-specific CD4+ T cells in IL-27R−/− mice cor-
related with a moderate decrease, rather than expected increase 
in demyelination (15). It cannot be excluded that despite their 
increased frequency, the overall low numbers of myelin-specific 
CD4+ T cells are insufficient to achieve effector threshold levels 
required to affect myelin loss or tissue damage. Prolonged studies 
may be necessary to reveal altered tissue damage, as demyelina-
tion in IL-27R−/− mice was quantified only until day 30 p.i. (15). 
It  also remains a possibility that compensatory mechanisms 
occur in the absence of Tr1 cells. IL-10 is critical in limiting 
demyelination during JHMV persistence and is produced by both 
Foxp3+ Tregs and Tr1 cells. Surprisingly however, no difference in 
IL-10 mRNA levels was detected between WT and IL-27R−/− mice 
during chronic JHMV infection (42), indicating another cell type 
may compensate for the lack of Tr1 cells.
Altogether, our study demonstrates the importance of distinct 
Treg populations in controlling SR T cells both at the induction 
and effector site during chronic encephalomyelitis. These are the 
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first data to show a differential role of Foxp3+ Tregs versus Tr1 
cells in limiting SR CD4+ T cells in CLN and CNS, respectively, 
thereby maximizing prevention of autoimmunity. Deciphering 
the mechanisms by which distinct Treg subsets function in spe-
cific anatomical locations and different inflammatory conditions 
may lead to potential future therapeutic strategies to prevent or 
limit autoimmunity following viral infections.
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